Seeliger, Tabea http://orcid.org/0000-0002-6018-6826
Dreyer, Henrike Neelke
Siemer, Janna Margaretha
Bönig, Lena
Gingele, Stefan
Dohrn, Maike Franziska
Prenzler, Nils
Ernst, Diana
Witte, Torsten
Skripuletz, Thomas http://orcid.org/0000-0001-8550-335X
Funding for this research was provided by:
Medizinischen Hochschule Hannover
Medizinische Fakultät, RWTH Aachen University (IZKF TN1-9/IA 532009)
Medizinische Hochschule Hannover (MHH)
Article History
Received: 25 July 2022
Revised: 15 October 2022
Accepted: 17 October 2022
First Online: 4 November 2022
Declarations
:
: The authors declare no conflict of interest. Outside the submitted work, the authors received honoraria for lectures, travel grants, or research grants. TSe received a travel support to attend a scientific meeting by Abbvie, honoraria for preparation of a manuscript by Springer and was funded by the Ellen-Schmidt-Scholarship of the Hannover Medical School. JMS received a travel grant by the Gesellschaft der Freunde der MHH e.V. SG reports research support from Alnylam Pharmaceuticals, CSL Behring, Else Kröner Fresenius Foundation, Deutsche Forschungsgemeinschaft and Hannover Biomedical Research School (HBRS) and honoraria for lectures from Alnylam and Merck. MFD received financial reimbursement for consulting and advisory board activities and travel support to attend scientific meetings by Akcea Therapeuticals Inc., Alnylam Pharmaceuticals Inc., Amicus Therapeutics, and Pfizer Pharmaceuticals. MFD further received research funding by Pfizer Pharmaceuticals (ASPIRE 2018). DE received presentation honoraria from Abbvie, Amgen, BMS, Chugai, Cilag-Janssen, Galapagos, GSK, Medac, Lilly, Pfizer, Novartis, Roche and participated in advisory boards for Abbvie, Galapagos, Amgen and Novartis. TW received honoraria for lectures by Abbvie, BMS, Chugai, Galapagos, Janssen, Lilly, Pfizer, UCB and Roche. TSk reports research support from Bristol-Myers Squibb, Claudia von Schilling Foundation, Else Kröner Fresenius Foundation, and Sanofi Aventis, and honoraria for lectures and travel grants from Alexion, Alnylam, Bayer Vital, Biogen, Celgene, CSL Behring, Euroimmun, Janssen, Merck, Novartis, Pfizer, Roche, Sanofi Aventis, Siemens, and Sobi. HND, LB, NP and TW have nothing to declare.
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Local Ethics Committee) of the Hannover Medical School (No. 8172_BO_K_2018).